Results 1 to 10 of about 1,635,060 (314)

Combination therapy in the treatment of hypertension

open access: yesDrugs in Context, 2018
Hypertension is a major preventable risk factor for atherosclerosis and ischemic heart disease. Although modern and effective antihypertensive drugs are available, most patients remain with a suboptimal blood pressure control.
Alberto Francisco Rubio-Guerra
doaj   +2 more sources

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2016
Stanley S Schwartz,1,2 Arie Katz3 1University of Pennsylvania, Philadelphia, PA, USA; 2Main Line Health System, Ardmore, PA, USA; 3AstraZeneca, Fort Washington, PA, USA Abstract: In type 2 diabetes (T2D), early combination therapy using agents that ...
Schwartz SS, Katz A
doaj   +1 more source

Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future

open access: yesBioengineering, 2022
As a safe and minimal-invasive modality, thermal therapy has become an effective treatment in cancer treatment. Other than killing the tumor cells or destroying the tumor entirely, the thermal modality results in profound molecular, cellular and ...
Qizheng Dai   +3 more
doaj   +1 more source

Targeted c-Myc Inhibition and Systemic Temozolomide Therapy Extend Survival in Glioblastoma Xenografts

open access: yesBioengineering, 2023
Glioblastoma is a highly aggressive disease with poor patient outcomes despite current treatment options, which consist of surgery, radiation, and chemotherapy.
Laxmi Dhungel   +4 more
doaj   +1 more source

Combination Antithrombotic Therapies [PDF]

open access: yesCirculation, 2010
Atherothrombosis is the major pathophysiological process responsible for the occurrence of severe ischemic events in patients with cardiovascular diseases. In the United States, atherothrombosis strongly influenced mortality in 2004: One in 2.8 deaths was due to CVD, 1 in 5 deaths to coronary heart disease, and 1 in 17 deaths to stroke.1 Because ...
Paul A, Gurbel, Udaya S, Tantry
openaire   +2 more sources

Combination therapy for cough and bronchial obstruction in childhood

open access: yesМедицинский совет, 2019
The inflammatory process in the bronchial mucosa of various origins (infectious, allergic, irritative, etc.) cause changes in the sputum production and its rheological properties, slowing of mucociliary clearance.
Yu. L. Mizernitskiy   +2 more
doaj   +1 more source

Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program

open access: yesРоссийский кардиологический журнал, 2021
Aim. In practice, to evaluate the efficacy, safety and long-term adherence to therapy with a fixed-dose combination of ramipril/indapamide (Konsilar-D24) in patients with grade 1-2 hypertension (HTN) who have not achieved blood pressure (BP) control with
A. O. Konradi   +9 more
doaj   +1 more source

Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy

open access: yesCancer Treatment and Research Communications, 2022
The autophagy pathway is the process whereby cells keep cellular homeostasis and respond to stress via recycling their damaged cellular proteins, organelles, and other cellular components. In the context of cancer, autophagy is a dual-edge sword pro- and
Ali Salimi-Jeda   +8 more
doaj   +1 more source

Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria : a literature review and meta-analysis of individual patient data [PDF]

open access: yes, 2015
Artemisinin-resistant Plasmodium falciparum has emerged in the Greater Mekong sub-region and poses a major global public health threat. Slow parasite clearance is a key clinical manifestation of reduced susceptibility to artemisinin.
Wwarn Artemisinin based Combination Therapy Africa Baseline Stud,
core   +1 more source

Combination Therapy for Myelomatosis [PDF]

open access: yesBMJ, 1974
Twenty-eight patients with multiple myeloma have been treated with a quadruple chemotherapeutic regimen consisting of 1, 3 bis (2-chloroethyl)-1-nitrosourea (BCNU), cyclophosphamide, melphalan, and prednisolone. Nineteen new patients and nine who had escaped from previous single-agent therapy were included in the study.
L, Azam, I W, Delamore
openaire   +2 more sources

Home - About - Disclaimer - Privacy